“The data submitted in this EUA request were consistent with the recommendations set forth in the FDA Guidance on Emergency Use Authorization for Vaccines to Prevent COVID-19 and met the prespecified success criteria established in the protocol,” reads FDA’s public assessment of their review of Pfizer’s vaccine application.
Click below to read full FDA assessment report:
- Advertisement -
